مباشر

Endpoints NewsParabilis reveals IPO plans the day after Regeneron deal as listings heat up Endpoints NewsGHO Capital, CBC Group to merge, forming what could be the largest healthcare specialist investor FierceBiotechParabilis, fresh from inking Regeneron pact, plans IPO to fund tumor drug’s phase 3 push FierceBiotechPfizer furthers pneumococcal efforts, remains ‘comfortable’ taking on emerging threats: vaccine chief LabiotechEight Swedish companies spearheading the country’s biotech scene eLifeTwelve phosphomimetic mutations induce the assembly of recombinant full-length human tau into paired helical filaments IlluminaIllumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact - TradingView IlluminaIllumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact - PR Newswire Endpoints NewsTrumpRx adds hundreds of generic medicines to site Clinical OMICsSmart Wristband Detects Cardiac Arrest with 92% Sensitivity in Early Clinical Study Endpoints NewsAnother Paragon offshoot chooses reverse merger, this time for migraine drugs 10x Genomics BlogWhy 10x Genomics Stock Is Surging Today - TipRanks

Labiotech ٢٠ مايو ٢٠٢٦

Eight Swedish companies spearheading the country’s biotech scene

As Sweden's life sciences sector continues to grow, we explore 8 biotech companies in Sweden that are leading the way in the industry. The post Eight Swedish co...

As Sweden's life sciences sector continues to grow, we explore 8 biotech companies in Sweden that are leading the way in the industry. The post Eight Swedish companies spearheading the country’s biotech scene in 2026 appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.